Serum adropin levels as a potential biomarker for predicting diabetic kidney disease progression
BackgroundTo investigate the value of serum adropin in predicting chronic kidney disease (CKD) progression in subjects with type 2 diabetes (T2D).Materials and methodsSerum adropin levels were measured in normal control and T2D patients with various stage of CKD. CKD progression was defined as ≥ 30%...
Saved in:
Main Authors: | I-Wen Chen, Cheng-Wei Lin, Chia-Ni Lin, Szu-Tah Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1511730/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adropin as an indicator of T2DM and its complications
by: Hu Zhang, et al.
Published: (2022-11-01) -
The Correlation of Serum Adropin with Cardiovascular Risk Factors in the Experimental Rat Model of Chronic Kidney Disease and Its Implication in the Ameliorative Effect of Angiotensin-Converting Enzyme Inhibitors
by: Samaa Salah Abd-El-Fatah, et al.
Published: (2024-12-01) -
Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
by: Yu-Ling Lin, et al.
Published: (2025-01-01) -
Adropin: a key player in immune cell homeostasis and regulation of inflammation in several diseases
by: Junmin Wang, et al.
Published: (2025-01-01) -
Characterization of diabetic kidney disease in 235 patients: clinical and pathological insights with or without concurrent non-diabetic kidney disease
by: Mengjie Jiang, et al.
Published: (2025-01-01)